Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling

Trends in Biochemical Sciences

Volumn 35, Issue 12, 2010, Pages 669-675

  Verdin, Eric ^a,b   Hirschey, Matthew D ^a,b   Finley, Lydia W S ^c   Haigis, Marcia C ^c  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CARBAMOYL PHOSPHATE SYNTHASE; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; UNCLASSIFIED DRUG;

APOPTOSIS; CELL METABOLISM; CELL STRESS; CITRIC ACID CYCLE; CYTOLOGY; ELECTRON TRANSPORT; ENERGY YIELD; FATTY ACID OXIDATION; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; SIGNAL TRANSDUCTION; SIRTUINS;

MAMMALIA;

EID: 78649328799     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2010.07.003     Document Type: Review

References (65)

1. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
2. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
3. Ryan M.T., Hoogenraad N.J. Mitochondrial-nuclear communications. Annu. Rev. Biochem. 2007, 76:701-722.
4. Scarpulla R.C. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim. Biophys. Acta 2002, 1576:1-14.
5. Pagliarini D.J., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
6. Johnson D.T., et al. Tissue heterogeneity of the mammalian mitochondrial proteome. Am. J. Physiol. Cell Physiol. 2007, 292:C689-C697.
7. Kelly D.P., Scarpulla R.C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 2004, 18:357-368.
8. Kowaltowski A.J., et al. Mitochondria and reactive oxygen species. Free Rad. Biol. Med. 2009, 47:333-343.
9. Fariss M.W., et al. Role of mitochondria in toxic oxidative stress. Mol. Interv. 2005, 5:94-111.
10. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
11. Bevilacqua L., et al. Long-term caloric restriction increases UCP3 content but decreases proton leak and reactive oxygen species production in rat skeletal muscle mitochondria. Am. J. Physiol. Endocrinol. Metab. 2005, 289:E429-E438.
12. Hagen T.M., et al. Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3064-3069.
13. Sastre J., et al. Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology 1996, 24:1199-1205.
14. Short K.R., et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5618-5623.
15. Merry B.J. Oxidative stress and mitochondrial function with aging--the effects of calorie restriction. Aging Cell 2004, 3:7-12.
16. Hunt N.D., et al. Bioenergetics of aging and calorie restriction. Ageing Res. Rev. 2006, 5:125-143.
17. Navarro A., Boveris A. The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 2007, 292:C670-c686.
18. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 1999, 260:273-279.
19. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273:793-798.
20. Ahuja N., et al. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J. Biol. Chem. 2007, 282:33583-33592.
21. Haigis M.C., et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006, 126:941-954.
22. +-dependent protein deacetylase. Biochem. J. 2008, 411:e11-e13.
23. Bao J., et al. Characterization of the murine SIRT3 mitochondrial localization sequence and comparison of mitochondrial enrichment and deacetylase activity of long and short SIRT3 isoforms. J. Cell Biochem. 2010, 110:238-247.
24. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 2010, 5:253-295.
25. Blander G., Guarente L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73:417-435.
26. Schwer B., Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008, 7:104-112.
27. Michishita E., et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 2005, 16:4623-4635.
28. Onyango P., et al. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:13653-13658.
29. Schwer B., et al. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 2002, 158:647-657.
30. Michishita E., et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008, 452:492-496.
31. Yang B., et al. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle 2009, 8:2662-2663.
32. Jin L., et al. Crystal structures of human SIRT3 displaying substrate-induced conformational changes. J. Biol. Chem. 2009, 284:24394-24405.
33. Schlicker C., et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 2008, 382:790-801.
34. +-dependent deacetylase SIRT5 by suramin. Structure 2007, 15:377-389.
35. Zhao S., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
36. Schwer B., et al. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 2009, 8:604-606.
37. Kim S.C., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607-618.
38. Hirschey M.D., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
39. Schwer B., et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10224-10229.
40. Hallows W.C., et al. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10230-10235.
41. Kurtz D.M., et al. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:15592-15597.
42. Ahn B.H., et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14447-14452.
43. Cimen H., et al. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010, 49:304-311.
44. Law I.K., et al. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics 2009, 9:2444-2456.
45. +-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J. Biol. Chem. 2010, 285:7417-7429.
46. Lombard D.B., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell Biol. 2007, 27:8807-8814.
47. Nakagawa T., et al. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009, 137:560-570.
48. Ogura M., et al. Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1. Biochem. Biophys. Res. Commun. 2010, 393:73-78.
49. Rodgers J.T., et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005, 434:113-118.
50. Gerhart-Hines Z., et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 2007, 26:1913-1923.
51. Butow R.A., Avadhani N.G. Mitochondrial signaling: the retrograde response. Mol. Cell 2004, 14:1-15.
52. +-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol. Rev. 2008, 88:421-449.
53. Finley L.W., Haigis M.C. The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res. Rev. 2009, 8:173-188.
54. Palacios O.M., et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging 2009, 1:771-783.
55. Shi T., et al. SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells. J. Digest. Dis. 2010, 11:55-62.
56. Pillai V.B., et al. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 2010, 285:3133-3144.
57. + and NADH in cellular functions and cell death. Front. Biosci. 2006, 11:3129-3148.
58. Canto C., Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 2009, 20:98-105.
59. + metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
60. Kim H.S., et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
61. Allison S.J., Milner J. SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 2007, 6:2669-2677.
62. + levels dictate cell survival. Cell 2007, 130:1095-1107.
63. Sundaresan N.R., et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 2009, 119:2758-2771.
64. Finnin M.S., et al. Structure of the histone deacetylase SIRT2. Nat. Struct. Biol. 2001, 8:621-625.
65. Pettersen E.F., et al. UCSF Chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.